glp-1 compounding news november 2025 Patients struggle as compounded access rapidly shrinks Alarming rise in weight loss

With decades of expertise in solid-phase peptide synthesis and industrial-scale production infrastructure, Bachem helps pharmaceutical and biotech partners develop scalable processes that support both clinical development and long-term commercial supply

5-Amino-1MQ Dosage Protocol Guide Research Insights Research into 5-amino-1mq dosage protocol structures reveals a persistent gap between published animal studies and practical human application

Any weight loss can reduce the number of calories your body burns at rest, making it easier to regain weight

Even though GLP-1 medications suppress appetite, its important to consume adequate protein, vitamins, minerals, and overall calories to support your health

In KONFIDENT-S, 90.3% of attacks treated with sebetralstat reached end of progression within 4 h of administration

10.1172/JCI99490 31 de CarvalhoC.CaramujoM